Last $3.81 USD
Change Today +0.18 / 4.96%
Volume 3.8M
BIOC On Other Exchanges
Symbol
Exchange
NASDAQ CM
Stuttgart
As of 10:17 AM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for biocept inc (BIOC)

Biocept, Inc. uses little or no debt in its capital structure and may have less financial risk than the industry aggregate. Accounts Receivable are among the industry's worst with 38.18 days worth of sales outstanding. This implies that revenues are not being collected in an efficient manner. Last, Biocept, Inc. is among the least efficient in its industry at managing inventories, with 12.07 days of its Cost of Goods Sold tied up in Inventories.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Dec 31
2012
Dec 31
2013
Restated
--
--
4 Year
Trend
Assets    
Cash and Equivalents0.40.20.1--
TOTAL CASH AND SHORT TERM INVESTMENTS0.40.20.1--
Accounts Receivable0.00.00.0--
TOTAL RECEIVABLES0.00.00.0--
Inventory--0.10.1--
Prepaid Expenses0.40.30.3--
TOTAL CURRENT ASSETS0.80.60.4--
Gross Property Plant and Equipment4.74.74.7--
Accumulated Depreciation-3.7-4.1-4.4--
NET PROPERTY PLANT AND EQUIPMENT1.00.60.4--
Other Long-Term Assets0.30.30.0--
TOTAL ASSETS2.11.50.8--
    
LIABILITIES & EQUITY    
Accounts Payable1.01.41.5--
Accrued Expenses1.23.31.7--
Short-Term Borrowings----1.7--
Current Portion of Long-Term Debt/Capital Lease12.421.90.2--
Other Current Liabilities, Total0.91.0----
TOTAL CURRENT LIABILITIES15.527.65.2--
Long-Term Debt1.70.7----
Other Non-Current Liabilities0.30.50.5--
TOTAL LIABILITIES17.428.95.6--
Preferred Stock Convertible0.00.0----
TOTAL PREFERRED EQUITY0.00.0----
Common Stock0.00.00.0--
Additional Paid in Capital85.585.8118.5--
Retained Earnings-100.9-113.2-123.3--
TOTAL COMMON EQUITY-15.4-27.4-4.8--
TOTAL EQUITY-15.4-27.4-4.8--
TOTAL LIABILITIES AND EQUITY2.11.50.8--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIOC:US $3.81 USD +0.18

BIOC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Atossa Genetics Inc $1.98 USD -0.05
BioMerieux €96.24 EUR -0.32
Daiichi Sankyo Co Ltd ¥1,904 JPY +14.50
Fluidigm Corp $42.32 USD -1.85
Illumina Inc $191.71 USD -2.35
View Industry Companies
 

Industry Analysis

BIOC

Industry Average

Valuation BIOC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 183.6x
Price/Book 4.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 335.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOCEPT INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.